Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease.
D000293:Adolescent; D017668:Age of Onset; D001656:Biliary Atresia / Q000150:complications / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D015897:Comorbidity; D011464:Epoprostenol / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D005500:Follow-Up Studies; D020065:Hepatopulmonary Syndrome / Q000209:etiology / Q000601:surgery* / Q000628:therapy; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000601:surgery*; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology / Q000601:surgery* / Q000628:therapy; D000860:Hypoxia / Q000209:etiology / Q000628:therapy; D007223:Infant; D007231:Infant, Newborn; D017093:Liver Failure / Q000150:complications*; D016031:Liver Transplantation / Q000706:statistics & numerical data*; D008297:Male; D010102:Oxygen Inhalation Therapy; D011183:Postoperative Complications; D012189:Retrospective Studies
D011464:Epoprostenol